Inovio Pharmaceuticals, Inc. (INO)
USD 1.46
(-7.59%)
USD 1.46
(-7.59%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -130.39 Million USD | 50.95% |
| 2022 | -270.9 Million USD | 8.45% |
| 2021 | -296.55 Million USD | -285.11% |
| 2020 | -149.56 Million USD | 27.86% |
| 2019 | -107.34 Million USD | -18.03% |
| 2018 | -89.8 Million USD | -7.8% |
| 2017 | -84.73 Million USD | -10.23% |
| 2016 | -74.14 Million USD | -117.93% |
| 2015 | -33.36 Million USD | 9.75% |
| 2014 | -37.92 Million USD | -258.24% |
| 2013 | -19.44 Million USD | 193.81% |
| 2012 | -22.64 Million USD | 12.57% |
| 2011 | -21.63 Million USD | -50.56% |
| 2010 | -17.11 Million USD | -77.72% |
| 2009 | -13.95 Million USD | 13.31% |
| 2008 | -11.97 Million USD | 30.77% |
| 2007 | -10.18 Million USD | -47.7% |
| 2006 | -12.43 Million USD | -54.54% |
| 2005 | -11.37 Million USD | 26.44% |
| 2004 | -10.93 Million USD | -80.82% |
| 2003 | -6.04 Million USD | -14.49% |
| 2002 | -5.28 Million USD | 5.25% |
| 2001 | -5.57 Million USD | 33.39% |
| 2000 | -8.37 Million USD | -23.1% |
| 1999 | -8.96 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -32.36 Million USD | -6.35% |
| 2024 Q1 | -30.72 Million USD | -20.31% |
| 2023 FY | - USD | 50.95% |
| 2023 Q1 | -43.55 Million USD | 23.51% |
| 2023 Q3 | -35.55 Million USD | -1.58% |
| 2023 Q4 | -27.21 Million USD | 23.44% |
| 2023 Q2 | -35 Million USD | 19.64% |
| 2022 Q4 | -56.94 Million USD | -66.14% |
| 2022 Q3 | -34.27 Million USD | 66.66% |
| 2022 Q1 | -70.37 Million USD | 31.12% |
| 2022 Q2 | -102.8 Million USD | -46.08% |
| 2022 FY | - USD | 8.45% |
| 2021 Q3 | -58.37 Million USD | 27.91% |
| 2021 Q1 | -51.8 Million USD | -97.76% |
| 2021 Q4 | -102.16 Million USD | -75.01% |
| 2021 FY | - USD | -285.11% |
| 2021 Q2 | -80.97 Million USD | -56.3% |
| 2020 Q3 | -7.76 Million USD | 75.24% |
| 2020 Q2 | -31.36 Million USD | -189.29% |
| 2020 Q4 | -26.19 Million USD | -237.38% |
| 2020 FY | - USD | 27.86% |
| 2020 Q1 | -10.84 Million USD | 62.97% |
| 2019 Q2 | -23.44 Million USD | 14.25% |
| 2019 Q1 | -27.33 Million USD | 3.24% |
| 2019 Q3 | -23.65 Million USD | -0.93% |
| 2019 Q4 | -29.28 Million USD | -23.76% |
| 2019 FY | - USD | -18.03% |
| 2018 Q2 | -4.2 Million USD | 86.57% |
| 2018 FY | - USD | -7.8% |
| 2018 Q1 | -31.31 Million USD | -25.3% |
| 2018 Q3 | -25.67 Million USD | -510.3% |
| 2018 Q4 | -28.25 Million USD | -10.03% |
| 2017 Q2 | -8.42 Million USD | 60.13% |
| 2017 Q4 | -24.99 Million USD | 12.14% |
| 2017 FY | - USD | -10.23% |
| 2017 Q1 | -21.12 Million USD | 4.79% |
| 2017 Q3 | -28.44 Million USD | -237.81% |
| 2016 Q3 | -19.32 Million USD | 0.03% |
| 2016 Q2 | -19.32 Million USD | -33.77% |
| 2016 FY | - USD | -117.93% |
| 2016 Q4 | -22.18 Million USD | -14.82% |
| 2016 Q1 | -14.44 Million USD | -5.38% |
| 2015 FY | - USD | 9.75% |
| 2015 Q1 | -7.92 Million USD | 26.09% |
| 2015 Q2 | -16.61 Million USD | -109.53% |
| 2015 Q3 | 3.7 Million USD | 122.33% |
| 2015 Q4 | -13.7 Million USD | -469.59% |
| 2014 Q2 | -10.61 Million USD | -16.11% |
| 2014 Q1 | -9.13 Million USD | -176.19% |
| 2014 Q3 | -7.79 Million USD | 26.51% |
| 2014 Q4 | -10.72 Million USD | -37.56% |
| 2014 FY | - USD | -258.24% |
| 2013 Q2 | -3.98 Million USD | 15.53% |
| 2013 Q4 | -3.3 Million USD | -109.14% |
| 2013 Q3 | 36.2 Million USD | 1008.23% |
| 2013 FY | - USD | 193.81% |
| 2013 Q1 | -4.71 Million USD | 50.82% |
| 2012 Q3 | -6.41 Million USD | 35.12% |
| 2012 FY | - USD | 12.57% |
| 2012 Q1 | -1.44 Million USD | 81.85% |
| 2012 Q2 | -9.88 Million USD | -585.1% |
| 2012 Q4 | -9.59 Million USD | -49.58% |
| 2011 Q3 | -8.28 Million USD | 13.1% |
| 2011 Q4 | -7.95 Million USD | 4.01% |
| 2011 FY | - USD | -50.56% |
| 2011 Q1 | -6.33 Million USD | -26.56% |
| 2011 Q2 | -9.53 Million USD | -50.52% |
| 2010 Q1 | -4.91 Million USD | 3.74% |
| 2010 Q4 | -5 Million USD | -9.98% |
| 2010 Q3 | -4.55 Million USD | 11.16% |
| 2010 Q2 | -5.12 Million USD | -4.25% |
| 2010 FY | - USD | -77.72% |
| 2009 Q3 | -140.68 Thousand USD | 94.09% |
| 2009 FY | - USD | 13.31% |
| 2009 Q2 | -2.38 Million USD | 29.83% |
| 2009 Q1 | -3.39 Million USD | -11.14% |
| 2009 Q4 | -5.1 Million USD | -3527.76% |
| 2008 Q1 | -3.13 Million USD | -101.15% |
| 2008 FY | - USD | 30.77% |
| 2008 Q4 | -3.05 Million USD | -10.02% |
| 2008 Q3 | -2.77 Million USD | 25.97% |
| 2008 Q2 | -3.75 Million USD | -19.74% |
| 2007 FY | - USD | -47.7% |
| 2007 Q2 | -4.52 Million USD | -11.04% |
| 2007 Q1 | -4.07 Million USD | -12.07% |
| 2007 Q3 | -4.79 Million USD | -5.93% |
| 2007 Q4 | -1.55 Million USD | 67.5% |
| 2006 Q3 | -3.24 Million USD | -8.49% |
| 2006 Q2 | -2.99 Million USD | -16.61% |
| 2006 FY | - USD | -54.54% |
| 2006 Q1 | -2.56 Million USD | 6.0% |
| 2006 Q4 | -3.63 Million USD | -12.02% |
| 2005 FY | - USD | 26.44% |
| 2005 Q1 | -365.02 Thousand USD | 90.22% |
| 2005 Q2 | -2.02 Million USD | -454.51% |
| 2005 Q3 | -2.84 Million USD | -40.65% |
| 2005 Q4 | -2.72 Million USD | 4.16% |
| 2004 Q4 | -3.73 Million USD | -9.95% |
| 2004 Q3 | -3.39 Million USD | -46.01% |
| 2004 FY | - USD | -80.82% |
| 2004 Q2 | -2.32 Million USD | -56.85% |
| 2004 Q1 | -1.48 Million USD | 10.36% |
| 2003 Q1 | -1.6 Million USD | -26.66% |
| 2003 FY | - USD | -14.49% |
| 2003 Q4 | -1.65 Million USD | -6.55% |
| 2003 Q3 | -1.55 Million USD | -23.39% |
| 2003 Q2 | -1.25 Million USD | 21.47% |
| 2002 FY | - USD | 5.25% |
| 2002 Q4 | -1.26 Million USD | 3.27% |
| 2002 Q3 | -1.3 Million USD | 5.09% |
| 2002 Q2 | -1.37 Million USD | -5.8% |
| 2002 Q1 | -1.33 Million USD | 81.48% |
| 2001 Q1 | -1.71 Million USD | -2.28% |
| 2001 FY | - USD | 33.39% |
| 2001 Q4 | -7.02 Million USD | -357.28% |
| 2001 Q3 | -1.53 Million USD | 40.13% |
| 2001 Q2 | -2.56 Million USD | -16.69% |
| 2000 Q3 | -1.89 Million USD | -4.02% |
| 2000 Q1 | -2.36 Million USD | -69.36% |
| 2000 FY | - USD | -23.1% |
| 2000 Q4 | -2.12 Million USD | -8.55% |
| 2000 Q2 | -1.94 Million USD | 19.65% |
| 1999 Q1 | 1.2 Million USD | 170.83% |
| 1999 Q2 | -2.9 Million USD | -158.82% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | -1.7 Million USD | 6.67% |
| 1999 Q3 | -1.9 Million USD | 50.0% |
| 1998 Q4 | -3.1 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -6.86 Million USD | -1798.53% |
| Jaguar Health, Inc. | -33.13 Million USD | -293.562% |
| Keros Therapeutics, Inc. | -152.17 Million USD | 14.316% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -129.748% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | 49.508% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 228.177% |
| ContextLogic Inc. | -324 Million USD | 59.756% |
| MiMedx Group, Inc. | 40.51 Million USD | 421.818% |
| MEI Pharma, Inc. | 26.38 Million USD | 594.28% |
| AlloVir, Inc. | -190.14 Million USD | 31.426% |
| Novavax, Inc. | -487.39 Million USD | 73.247% |
| Aptorum Group Limited | -9.59 Million USD | -1258.382% |
| Ardelyx, Inc. | -55.35 Million USD | -135.558% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | 25.776% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -4638.769% |
| Vaxcyte, Inc. | -464.88 Million USD | 71.952% |
| Precigen, Inc. | -89.22 Million USD | -46.136% |
| Pharming Group N.V. | 9.87 Million USD | 1420.148% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | 18.018% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -472.845% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -667.864% |
| Avidity Biosciences, Inc. | -233.49 Million USD | 44.157% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -625.465% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -440.775% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -440.775% |
| Bicycle Therapeutics plc | -183.4 Million USD | 28.903% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -49.143% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -350.199% |
| Acelyrin, Inc. | -381.52 Million USD | 65.824% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 24748.587% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -290.556% |
| Senti Biosciences, Inc. | -61.33 Million USD | -112.585% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -16.105% |
| AbCellera Biologics Inc. | -192.15 Million USD | 32.144% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -321.923% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | 21.176% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -40520.257% |
| Chimerix, Inc. | -92.97 Million USD | -40.245% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -301.784% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -546.813% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -193.431% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -178.245% |
| Elevation Oncology, Inc. | -41.46 Million USD | -214.445% |
| Alkermes plc | 495.04 Million USD | 126.339% |
| Fortress Biotech, Inc. | -133.64 Million USD | 2.433% |
| Fortress Biotech, Inc. | -133.64 Million USD | 2.433% |
| Agenus Inc. | -145.92 Million USD | 10.645% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -68.588% |
| Dyadic International, Inc. | -8.22 Million USD | -1484.388% |
| ImmuCell Corporation | -2.5 Million USD | -5107.149% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -44707.912% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | 0.023% |
| Lantern Pharma Inc. | -15.78 Million USD | -725.955% |
| Immix Biopharma, Inc. | -16.13 Million USD | -708.093% |
| Incyte Corporation | 919.42 Million USD | 114.182% |
| IO Biotech, Inc. | -91.22 Million USD | -42.929% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -83.587% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -554.823% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -127.257% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | 17.051% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -1453.014% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -74.285% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 65.684% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 75.85% |
| NextCure, Inc. | -59.03 Million USD | -120.856% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -1208.096% |
| Onconetix, Inc. | -36.7 Million USD | -255.224% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 5934.05% |
| Opthea Limited | -200.01 Million USD | 34.811% |
| PDS Biotechnology Corporation | -40.08 Million USD | -225.287% |
| PureTech Health plc | -11.62 Million USD | -1021.45% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -66.118% |
| Seer, Inc. | -97.88 Million USD | -33.208% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -1011868.468% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -465.491% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -2031.775% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -345.659% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -121.791% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -449.362% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -6.788% |
| ChromaDex Corporation | -3.89 Million USD | -3248.511% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -1794.117% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -15.868% |
| CRISPR Therapeutics AG | -202.7 Million USD | 35.673% |
| Precision BioSciences, Inc. | -32.04 Million USD | -306.938% |
| Fate Therapeutics, Inc. | -172.22 Million USD | 24.292% |
| Innoviva, Inc. | 248.96 Million USD | 152.374% |
| Summit Therapeutics Inc. | 1 Million USD | 13126.076% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -109.642% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -99.481% |
| ESSA Pharma Inc. | -26.45 Million USD | -392.873% |
| GlycoMimetics, Inc. | -39.12 Million USD | -233.293% |
| GT Biopharma, Inc. | 5.97 Million USD | 2280.817% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | 36.916% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 250.199% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -154.575% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -1218.825% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | 44.895% |
| Aptose Biosciences Inc. | -52.26 Million USD | -149.466% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -21.02% |
| Soligenix, Inc. | -7.85 Million USD | -1560.429% |
| Century Therapeutics, Inc. | -121.2 Million USD | -7.576% |
| Kura Oncology, Inc. | -164.95 Million USD | 20.954% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -62.789% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -1192.792% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -13514.463% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -2926.016% |
| Autolus Therapeutics plc | -156.77 Million USD | 16.827% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -54.023% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -88.97% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -554.114% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | 31.11% |
| GRI Bio, Inc. | -10.89 Million USD | -1096.467% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -2787.495% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -6.436% |
| IGM Biosciences, Inc. | -253.35 Million USD | 48.535% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -25.627% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -241.936% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -750.511% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -728.235% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -129.38% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -21.744% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | 50.98% |
| Coherus BioSciences, Inc. | -193.93 Million USD | 32.767% |
| Verastem, Inc. | -83.16 Million USD | -56.784% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -157.832% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | 17.593% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -14.289% |
| Histogen Inc. | -10.5 Million USD | -1141.465% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -813.121% |
| Surrozen, Inc. | -41.13 Million USD | -217.014% |
| Organovo Holdings, Inc. | -14.8 Million USD | -780.663% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 4065925.507% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -122.081% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -154.203% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -505.372% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -1463.816% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | 21.483% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -164.708% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -439.564% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -766.096% |
| Apollomics, Inc. | -171.74 Million USD | 24.08% |
| Amarin Corporation plc | -50.9 Million USD | -156.163% |
| Mesoblast Limited | -61.33 Million USD | -112.602% |
| Turnstone Biologics Corp. | -56.23 Million USD | -131.872% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | 8.945% |
| Synaptogenix, Inc. | -8.3 Million USD | -1469.557% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -750.062% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -106.816% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -2621.318% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 30491.415% |
| Exelixis, Inc. | 196.6 Million USD | 166.322% |
| Better Therapeutics, Inc. | -38.26 Million USD | -240.785% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | 7.792% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 73.67% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1005.416% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 52843.764% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -341.914% |
| Gritstone bio, Inc. | -126.86 Million USD | -2.781% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -100.648% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -3159.82% |
| Avid Bioservices, Inc. | -11.48 Million USD | -1035.711% |
| Insmed Incorporated | -654.73 Million USD | 80.085% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -5695.88% |
| MediWound Ltd. | -4.89 Million USD | -2564.848% |
| OmniAb, Inc. | -49.73 Million USD | -162.193% |
| Alector, Inc. | -142.89 Million USD | 8.749% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -52.622% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -150.04% |
| Zai Lab Limited | -366.57 Million USD | 64.43% |
| Revance Therapeutics, Inc. | -290.63 Million USD | 55.136% |
| Aura Biosciences, Inc. | -83.69 Million USD | -55.791% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | 42.112% |
| Immunic, Inc. | -99.11 Million USD | -31.559% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | 0.971% |
| Veracyte, Inc. | -49.4 Million USD | -163.901% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -1745.871% |
| FibroGen, Inc. | -261.4 Million USD | 50.119% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1070.371% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -1762.376% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -596.65% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 108.996% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -412.906% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 426.876% |
| TG Therapeutics, Inc. | 26.1 Million USD | 599.582% |
| Galecto, Inc. | -37.51 Million USD | -247.533% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -240.758% |
| Fortrea Holdings Inc. | 167.3 Million USD | 177.938% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | 2.896% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -360.567% |
| XBiotech Inc. | -35.76 Million USD | -264.567% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -100.648% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -99.833% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -24.83% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -407.911% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -219.062% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 74.753% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -132.754% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -232529.255% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -12.082% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -488.154% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | 44.53% |
| NexImmune, Inc. | -28.16 Million USD | -362.913% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -2259.784% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -1005.733% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 102.802% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -413.512% |
| Scopus BioPharma Inc. | -11.71 Million USD | -1013.202% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -3.612% |
| Ainos, Inc. | -8.77 Million USD | -1386.26% |
| Pluri Inc. | -20.22 Million USD | -544.702% |
| Prothena Corporation plc | -190.1 Million USD | 31.412% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -1.711% |
| Celularity Inc. | -183.94 Million USD | 29.115% |
| Rallybio Corporation | -72.37 Million USD | -80.165% |
| Cue Biopharma, Inc. | -46.05 Million USD | -183.139% |
| MeiraGTx Holdings plc | -57.05 Million USD | -128.548% |
| Omeros Corporation | -163.61 Million USD | 20.304% |
| Humacyte, Inc. | -96.45 Million USD | -35.179% |
| Immunocore Holdings plc | -59.64 Million USD | -118.597% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -573.09% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -435.157% |
| Blueprint Medicines Corporation | -474.61 Million USD | 72.527% |
| CalciMedica, Inc. | -34.18 Million USD | -281.383% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -78.047% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -3.9% |
| Scholar Rock Holding Corporation | -168.45 Million USD | 22.594% |
| Sana Biotechnology, Inc. | -252.39 Million USD | 48.337% |
| Pulmatrix, Inc. | -12.64 Million USD | -931.085% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -295.532% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -47.389% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 74.247% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -28.826% |
| Cytokinetics, Incorporated | -456.68 Million USD | 71.448% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -290.708% |
| Nutriband Inc. | -5.12 Million USD | -2445.816% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -201.329% |
| Vor Biopharma Inc. | -114.37 Million USD | -14.007% |
| Roivant Sciences Ltd. | -996.51 Million USD | 86.915% |
| Evogene Ltd. | -23.2 Million USD | -461.933% |
| ProKidney Corp. | -147.66 Million USD | 11.7% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -102.047% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -85039.977% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 76.941% |
| CorMedix Inc. | -48.88 Million USD | -166.719% |
| BioLineRx Ltd. | -57.06 Million USD | -128.512% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -16.673% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -64450.012% |
| Atai Life Sciences N.V. | -36.31 Million USD | -259.095% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -63.979% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -60.357% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | 52.672% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -324.174% |
| MediciNova, Inc. | -9.87 Million USD | -1219.751% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -3.533% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -8421.17% |
| GeoVax Labs, Inc. | -26.66 Million USD | -388.928% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | 42.046% |
| Biomea Fusion, Inc. | -124.62 Million USD | -4.631% |
| PTC Therapeutics, Inc. | -330.34 Million USD | 60.528% |
| Mereo BioPharma Group plc | -26.05 Million USD | -400.426% |
| Cullinan Oncology, Inc. | -190.33 Million USD | 31.495% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | 43.294% |
| Absci Corporation | -95.45 Million USD | -36.597% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -334.275% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -21.727% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | 44.152% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -470.514% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | 37.263% |
| Allakos Inc. | -189.91 Million USD | 31.342% |
| Imunon, Inc. | -19.87 Million USD | -555.947% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -20.185% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 220.371% |
| BioAtla, Inc. | -122.24 Million USD | -6.667% |
| NLS Pharmaceutics AG | -11.79 Million USD | -1005.416% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -727.302% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | 56.579% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -214.597% |
| XOMA Corporation | -39.36 Million USD | -231.261% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -31.371% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -10.83% |
| aTyr Pharma, Inc. | -52.17 Million USD | -149.897% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -55.57% |
| Akero Therapeutics, Inc. | -148.63 Million USD | 12.272% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | 44.412% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -855.036% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -1521.315% |
| Akari Therapeutics, Plc | -16.8 Million USD | -676.045% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 69197.445% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 128.851% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -1940.987% |
| UroGen Pharma Ltd. | -63.83 Million USD | -104.275% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -91.991% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -1695.275% |
| Orgenesis Inc. | -60.71 Million USD | -114.749% |
| Entera Bio Ltd. | -8.8 Million USD | -1381.043% |
| GH Research PLC | -41.15 Million USD | -216.845% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -410.957% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -58.563% |
| Xencor, Inc. | -125.87 Million USD | -3.589% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -9040.337% |
| Replimune Group, Inc. | -230.19 Million USD | 43.357% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -546.857% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -1091.656% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -1940.987% |
| Portage Biotech Inc. | -18.19 Million USD | -616.474% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -8421.17% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -24.676% |
| OncoCyte Corporation | -23.12 Million USD | -463.902% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1053.866% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1038.106% |
| Purple Biotech Ltd. | -22.22 Million USD | -486.686% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -1934.181% |
| scPharmaceuticals Inc. | -46.06 Million USD | -183.083% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -632.136% |
| HilleVax, Inc. | -132.46 Million USD | 1.566% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -1126.286% |
| Tharimmune, Inc. | -9.3 Million USD | -1301.664% |
| Genprex, Inc. | -31.06 Million USD | -319.796% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | 30.468% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -315.867% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -16966.888% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 86506.606% |
| OKYO Pharma Limited | -15.74 Thousand USD | -827996.663% |
| Savara Inc. | -59.13 Million USD | -120.505% |
| Curis, Inc. | -45.13 Million USD | -188.866% |
| Daré Bioscience, Inc. | -30.7 Million USD | -324.705% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -758.336% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -1719.833% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -387.735% |
| BeiGene, Ltd. | -1.12 Billion USD | 88.406% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -699.886% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 69.717% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -44.334% |
| Erasca, Inc. | -121.31 Million USD | -7.486% |
| bluebird bio, Inc. | -167.16 Million USD | 21.997% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -2798.38% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 142.023% |
| DBV Technologies S.A. | -85.98 Million USD | -51.649% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -2798.38% |
| Moderna, Inc. | -3.28 Billion USD | 96.028% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -206.018% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -2208.623% |
| Molecular Templates, Inc. | 1.43 Million USD | 9218.253% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -117.856% |
| Travere Therapeutics, Inc. | -326.24 Million USD | 60.033% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | 4.886% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -175.284% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | 6.216% |
| Cogent Biosciences, Inc. | -205.86 Million USD | 36.66% |
| MacroGenics, Inc. | 2.01 Million USD | 6564.602% |
| RenovoRx, Inc. | -11.39 Million USD | -1044.785% |
| Adicet Bio, Inc. | -136.53 Million USD | 4.5% |
| Prime Medicine, Inc. | -193.75 Million USD | 32.705% |
| Aditxt, Inc. | -25.45 Million USD | -412.182% |
| Adagene Inc. | -14.95 Million USD | -772.135% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1683.711% |
| Quantum-Si incorporated | -91.8 Million USD | -42.032% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 118.303% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 203.113% |
| SciSparc Ltd. | -5.28 Million USD | -2368.592% |
| Vericel Corporation | 2.86 Million USD | 4652.759% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -136853.853% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -501.118% |
| Generation Bio Co. | -133.3 Million USD | 2.182% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -57.041% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -51.577% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | 42.669% |
| Invivyd, Inc. | -196.61 Million USD | 33.682% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 65.15% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -1305.864% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 580.191% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1167.779% |
| 2seventy bio, Inc. | -206.41 Million USD | 36.832% |
| ADMA Biologics, Inc. | 5.12 Million USD | 2646.7% |
| Clene Inc. | -43.24 Million USD | -201.545% |
| Capricor Therapeutics, Inc. | -23 Million USD | -466.696% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -168.975% |
| GeoVax Labs, Inc. | -26.66 Million USD | -388.928% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | 56.473% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -255.005% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 653.137% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 2755.484% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -301.425% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | 17.685% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 80.945% |
| Evaxion Biotech A/S | -21.4 Million USD | -509.218% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -96.328% |
| Verve Therapeutics, Inc. | -217.66 Million USD | 40.097% |
| Trevena, Inc. | -35.28 Million USD | -269.505% |
| Surrozen, Inc. | -41.13 Million USD | -217.014% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -63.824% |
| Cingulate Inc. | -22.95 Million USD | -468.102% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -1647.635% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -249.733% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -1485.037% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -27.502% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -92.241% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -123.379% |
| Clearmind Medicine Inc. | -8.71 Million USD | -1396.913% |
| Kronos Bio, Inc. | -121.83 Million USD | -7.027% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -75.393% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -5240.799% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -29.322% |
| Statera Biopharma, Inc. | 38.93 Million USD | 434.895% |
| ImmunityBio, Inc. | -436.18 Million USD | 70.106% |
| Korro Bio, Inc. | -80.9 Million USD | -61.168% |
| Kineta, Inc. | -15.71 Million USD | -729.776% |
| BioVie Inc. | -31.95 Million USD | -308.107% |
| Codexis, Inc. | -49.28 Million USD | -164.576% |
| Celularity Inc. | -183.94 Million USD | 29.115% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | 41.135% |
| Celcuity Inc. | -58.3 Million USD | -123.617% |
| Virax Biolabs Group Limited | -6.6 Million USD | -1872.888% |
| Cibus, Inc. | -314.58 Million USD | 58.551% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -286.538% |
| IN8bio, Inc. | -28.5 Million USD | -357.448% |
| Kodiak Sciences Inc. | -259.02 Million USD | 49.66% |
| Annexon, Inc. | -141.57 Million USD | 7.9% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -15.801% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -103.114% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -366.432% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | 43.311% |
| Eyenovia, Inc. | -24.1 Million USD | -440.906% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 391.155% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -40144.143% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -76.672% |
| Arcellx, Inc. | -64.14 Million USD | -103.275% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -189.668% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -5.6% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -322.223% |
| Moolec Science SA | -52.07 Million USD | -150.388% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -152.666% |
| Geron Corporation | -174.78 Million USD | 25.398% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -222.614% |
| Royalty Pharma plc | 1.88 Billion USD | 106.909% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -9.029% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -1298.407% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -528.671% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | 21.489% |
| Humacyte, Inc. | -96.45 Million USD | -35.179% |
| Structure Therapeutics Inc. | -102.45 Million USD | -27.262% |
| 89bio, Inc. | -134.46 Million USD | 3.028% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -65.314% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 3317.942% |
| Genelux Corporation | -24.16 Million USD | -439.586% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -285.772% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | 20.233% |
| Notable Labs, Ltd. | -14.4 Million USD | -805.493% |
| Liquidia Corporation | -70.05 Million USD | -86.137% |
| Mustang Bio, Inc. | -48.06 Million USD | -171.292% |
| Immunovant, Inc. | -269.97 Million USD | 51.703% |
| Quantum-Si incorporated | -91.8 Million USD | -42.032% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -83.686% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -575.321% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -27.819% |
| Acasti Pharma Inc. | -11.3 Million USD | -1053.801% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -485.942% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -750.511% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | 38.06% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -2953.409% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -721.102% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -353.124% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -252.123% |
| PepGen Inc. | -83.58 Million USD | -56.004% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -341.944% |
| United Therapeutics Corporation | 1.38 Billion USD | 109.402% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -469.468% |
| Solid Biosciences Inc. | -93.43 Million USD | -39.554% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -2632.57% |
| Immuneering Corporation | -58.06 Million USD | -124.577% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 4065925.507% |
| Silo Pharma, Inc. | -3.62 Million USD | -3495.79% |
| Belite Bio, Inc | -31.52 Million USD | -313.559% |
| XOMA Corporation | -39.36 Million USD | -231.261% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -93.324% |
| Bionomics Limited | -9.83 Million USD | -1225.517% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -55.255% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -276.787% |
| uniQure N.V. | -253.1 Million USD | 48.482% |
| Cassava Sciences, Inc. | -95.68 Million USD | -36.268% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -1683.711% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -0.685% |
| Forte Biosciences, Inc. | -32.47 Million USD | -301.487% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -1519.669% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -362.068% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -40144.143% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -1070.371% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -720.018% |
| Altimmune, Inc. | -87.93 Million USD | -48.281% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -41.608% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -276.787% |
| Compugen Ltd. | -12.51 Million USD | -941.795% |
| Peak Bio, Inc. | -1356.23 USD | -9614126.496% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -168.305% |
| Benitec Biopharma Inc. | -22.49 Million USD | -479.773% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 46.187% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -356.823% |
| Zura Bio Limited | -60.56 Million USD | -115.298% |
| PolyPid Ltd. | -20.26 Million USD | -543.493% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -735.144% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -356.823% |
| Instil Bio, Inc. | -146.12 Million USD | 10.766% |
| argenx SE | -216.02 Million USD | 39.64% |
| Immunome, Inc. | -28.27 Million USD | -361.218% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -168.997% |
| Verona Pharma plc | -52.46 Million USD | -148.517% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -37.584% |
| Shattuck Labs, Inc. | -87.61 Million USD | -48.823% |
| CervoMed Inc. | -2.17 Million USD | -5903.618% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -6.665% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -927.267% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -170.667% |
| Moolec Science SA | -52.07 Million USD | -150.388% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -660.742% |
| AnaptysBio, Inc. | -143.16 Million USD | 8.922% |
| Design Therapeutics, Inc. | -66.32 Million USD | -96.594% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -61.002% |
| NeurAxis, Inc. | -6.66 Million USD | -1856.503% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -245.407% |
| Lumos Pharma, Inc. | -36.57 Million USD | -256.552% |
| Achilles Therapeutics plc | -70.44 Million USD | -85.104% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -37.584% |
| 180 Life Sciences Corp. | -22.13 Million USD | -489.098% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 2336.842% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -5240.799% |
| Nutriband Inc. | -5.12 Million USD | -2445.816% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -18.809% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -135.227% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -157.945% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -99.75% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -140.974% |
| Palisade Bio, Inc. | -12.28 Million USD | -961.73% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -187.357% |
| Beam Therapeutics Inc. | -156.47 Million USD | 16.669% |
| Neurogene Inc. | -52.28 Million USD | -149.38% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | 4.468% |
| AEON Biopharma, Inc. | -48.36 Million USD | -169.62% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -40.178% |
| Sesen Bio, Inc. | -50.84 Million USD | -156.473% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -59.145% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -955.796% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 69.494% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -23.949% |
| Athira Pharma, Inc. | -116.7 Million USD | -11.729% |
| Vaccinex, Inc. | -19.74 Million USD | -560.275% |
| HCW Biologics Inc. | -23.57 Million USD | -453.065% |
| XOMA Corporation | -39.36 Million USD | -231.261% |
| Nektar Therapeutics | -243.1 Million USD | 46.365% |
| Arvinas, Inc. | -394.8 Million USD | 66.973% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 69197.445% |
| Merus N.V. | -149.2 Million USD | 12.611% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -39.471% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -317.118% |
| Rezolute, Inc. | -68.42 Million USD | -90.566% |
| Clene Inc. | -43.24 Million USD | -201.545% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -745.477% |
| BeyondSpring Inc. | -21.54 Million USD | -505.344% |
| Synlogic, Inc. | -55.16 Million USD | -136.383% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -979.128% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -1125.249% |
| Peak Bio, Inc. | -1356.23 USD | -9614126.496% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -301.636% |
| Krystal Biotech, Inc. | 17.9 Million USD | 828.279% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -10.106% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | 61.801% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -2730.63% |
| MannKind Corporation | 15.12 Million USD | 961.861% |
| Ikena Oncology, Inc. | -74.39 Million USD | -75.264% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -935.425% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 741.467% |
| Gossamer Bio, Inc. | -172.15 Million USD | 24.258% |
| CohBar, Inc. | -12.06 Million USD | -980.67% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -411.157% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -334.275% |
| Legend Biotech Corporation | -477.87 Million USD | 72.714% |
| Mural Oncology plc | -192.72 Million USD | 32.342% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -14.324% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -707.611% |
| Disc Medicine, Inc. | -91.02 Million USD | -43.247% |
| Champions Oncology, Inc. | -5.05 Million USD | -2479.957% |
| REGENXBIO Inc. | -239.46 Million USD | 45.549% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -1116.54% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -133.86% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -236.334% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -15.589% |
| Vaxart, Inc. | -74.72 Million USD | -74.499% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -270.342% |
| Cellectis S.A. | -98.09 Million USD | -32.923% |
| Longeveron Inc. | -20.06 Million USD | -550.005% |
| Repare Therapeutics Inc. | -114.27 Million USD | -14.105% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 70.311% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -74.292% |
| Revolution Medicines, Inc. | -430.58 Million USD | 69.717% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -1973.319% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -323.499% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -74.81% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 2759.413% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -1089.157% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 102.831% |
| Denali Therapeutics Inc. | -179.97 Million USD | 27.55% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -136853.853% |
| Veru Inc. | -89.97 Million USD | -44.918% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -385.122% |
| Cingulate Inc. | -22.95 Million USD | -468.102% |
| Passage Bio, Inc. | -98.34 Million USD | -32.591% |
| Context Therapeutics Inc. | -25.06 Million USD | -420.303% |
| Exicure, Inc. | -15.53 Million USD | -739.121% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 36.723% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -252.637% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -2086.816% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | 22.6% |
| Nuvalent, Inc. | -149.49 Million USD | 12.777% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -1503.349% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -51.805% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -332.073% |
| OmniAb, Inc. | -49.73 Million USD | -162.193% |
| Anew Medical, Inc. | -1.3 Million USD | -9923.602% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -954.602% |
| Lipocine Inc. | -16.32 Million USD | -698.834% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -95.577% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -75.486% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -241.936% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -234.216% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -487.797% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 76.078% |
| Ocugen, Inc. | -64.82 Million USD | -101.137% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -40.857% |
| Q32 Bio Inc. | -86.5 Million USD | -50.738% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -670.314% |
| Alumis Inc. Common Stock | -156.89 Million USD | 16.89% |
| Equillium, Inc. | -12.13 Million USD | -974.238% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -122.997% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -1549.82% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -591.327% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -179.258% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -22.611% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -628.988% |
| Dominari Holdings Inc. | -22.44 Million USD | -481.065% |
| Edesa Biotech, Inc. | -8.19 Million USD | -1492.048% |
| vTv Therapeutics Inc. | -25.41 Million USD | -413.108% |
| Bio-Techne Corporation | 326.66 Million USD | 139.916% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 66.12% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 160.258% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | 0.547% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -248.35% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | 13.706% |
| Nkarta, Inc. | -120.48 Million USD | -8.225% |
| BioCardia, Inc. | -11.56 Million USD | -1027.95% |
| Iterum Therapeutics plc | -34.58 Million USD | -277.071% |